[
  {
    "ts": null,
    "headline": "Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street’s reaction to the company’s latest data announcement regarding MariTide, and said: “Unlike Mounjaro or Ozempic, which needed to be injected once a week, Amgen’s MariTide is one shot per month. I prefer monthly over weekly […]",
    "url": "https://finnhub.io/api/news?id=175ab65f09b422490528522adbdabe337f02e012a1c54ba55c0bfa7d49bad466",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751127618,
      "headline": "Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”",
      "id": 135610413,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street’s reaction to the company’s latest data announcement regarding MariTide, and said: “Unlike Mounjaro or Ozempic, which needed to be injected once a week, Amgen’s MariTide is one shot per month. I prefer monthly over weekly […]",
      "url": "https://finnhub.io/api/news?id=175ab65f09b422490528522adbdabe337f02e012a1c54ba55c0bfa7d49bad466"
    }
  }
]